Aquinnah Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 16

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $4.15M

  • Investors
  • 8

Aquinnah General Information

Description

Developer of neurodegenerative stress granules intended for the treatment of critical diseases. The company leverages brain pathology to design innovative therapies to slow the progression of amyotrophic lateral sclerosis and other neuron diseases, enabling physicians and the medical community to combat sclerosis, Alzheimer's, and other neurodegenerative conditions.

Contact Information

Website
www.aquinnahpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 750 Main Street
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aquinnah Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 17-Jan-2019 $4.15M Completed Generating Revenue
4. Grant 15-Sep-2018 Completed Generating Revenue
3. Early Stage VC 25-Apr-2017 Completed Generating Revenue
2. Corporate 21-Dec-2015 $5M $5M Completed Startup
1. Grant 23-Nov-2015 $680K Completed Startup
To view Aquinnah’s complete valuation and funding history, request access »

Aquinnah Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurodegenerative stress granules intended for the treatment of critical diseases. The company leverages br
Drug Discovery
Cambridge, MA
16 As of 2024

Newton, MA
 

Guilford, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aquinnah Competitors (64)

One of Aquinnah’s 64 competitors is Pinteon Therapeutics, a Venture Capital-Backed company based in Newton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pinteon Therapeutics Venture Capital-Backed Newton, MA
Bioasis Technologies Corporation Guilford, CT
NeuroNascent Venture Capital-Backed Clarksville, MD
Tetra Therapeutics Formerly VC-backed Grand Rapids, MI
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 64 competitors. Get the full list »

Aquinnah Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Aquinnah Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017382360-B2 Compounds, compositions and methods of use Active 23-Dec-2016
AU-2017382360-A1 Compounds, compositions and methods of use Active 23-Dec-2016
CA-3047404-A1 Compounds, compositions and methods of use Pending 23-Dec-2016
EP-3557998-A4 Compouns, compositions and methods of use Active 23-Dec-2016
EP-3557998-A1 Compouns, compositions and methods of use Active 23-Dec-2016 A61P25/16
To view Aquinnah’s complete patent history, request access »

Aquinnah Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aquinnah Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alzheimers Association Corporation Minority
Tau Consortium Government
National Institutes of Health Government Minority
AbbVie Ventures Corporate Venture Capital Minority
Pfizer Ventures Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Aquinnah FAQs

  • When was Aquinnah founded?

    Aquinnah was founded in 2014.

  • Where is Aquinnah headquartered?

    Aquinnah is headquartered in Cambridge, MA.

  • What is the size of Aquinnah?

    Aquinnah has 16 total employees.

  • What industry is Aquinnah in?

    Aquinnah’s primary industry is Drug Discovery.

  • Is Aquinnah a private or public company?

    Aquinnah is a Private company.

  • What is Aquinnah’s current revenue?

    The current revenue for Aquinnah is .

  • How much funding has Aquinnah raised over time?

    Aquinnah has raised $15M.

  • Who are Aquinnah’s investors?

    Alzheimers Association, Tau Consortium, National Institutes of Health, AbbVie Ventures, and Pfizer Ventures are 5 of 8 investors who have invested in Aquinnah.

  • Who are Aquinnah’s competitors?

    Pinteon Therapeutics, Bioasis Technologies, NeuroNascent, Tetra Therapeutics, and Neurona Therapeutics are some of the 64 competitors of Aquinnah.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »